The Board of Directors of AstraZeneca Pharma India Limited at their meeting held on May 26, 2022, has Recommended Final Dividend of INR 8/- per equity share for the financial year 2021-22.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,244 INR | -3.06% | -1.82% | -5.00% |
1st Jan change | Capi. | |
---|---|---|
-5.00% | 1.62B | |
+31.52% | 690B | |
+24.02% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.49% | 235B | |
+4.10% | 199B | |
-10.47% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- ASTRAZEN Stock
- News AstraZeneca Pharma India Limited
- AstraZeneca Pharma India Limited Recommends Final Dividend for the Financial Year 2021-22